According to the latest report published by Data Bridge Market Research, the Artificial Intelligence (AI) in Drug Discovery Market
CAGR Value
The global artificial intelligence (AI) in drug discovery market was valued at USD 981.64 Million in 2024 and is expected to reach USD 1483.82 Million by 2032
During the forecast period of 2025 to 2032 the market is likely to...
According to the latest report published by Data Bridge Market Research, the Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market
CAGR Value
The Asia-Pacific Artificial Intelligence (AI) in drug discovery market was valued at USD 660.36 million in 2025 and is projected to reach USD 17,753.93 million by 2033, growing at a CAGR of 50.9%...
According to the latest report published by Data Bridge Market Research, the Europe Artificial Intelligence (AI) in Drug Discovery Market
CAGR Value
The Europe Artificial Intelligence (AI) in drug discovery market was valued at USD 916.45 million in 2025 and is projected to reach USD 26,113.04 million by 2033, growing at a CAGR of 52.0% from 2026 to...
The growing importance of glycans in biological processes is expanding research opportunities across diagnostics, drug discovery, personalized medicine, and biotechnology. The Glycomics Market was valued at USD 1.6 billion in 2022 and is projected to reach USD 4.9 billion by 2030, expanding at a CAGR of 14.6% from 2023 to 2030. The market is estimated to reach USD 2.8 billion in 2026,...
According to the latest report published by Data Bridge Market Research, the Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Market
CAGR Value
The Middle East and Africa Artificial Intelligence (AI) in drug discovery market was valued at USD 117.20 million in 2025 and is projected to reach USD 2,569.38 million by 2033, growing at...
The Pharma 4.0 market is moving rapidly toward a more connected, automated, and data-driven pharmaceutical ecosystem. The market was valued at USD 15.0 billion in 2025 and is projected to reach USD 61.7 billion by 2033, expanding at a 19.5% CAGR from 2026 to 2033. The market is estimated at USD 17.7 billion in 2026. Pharma 4.0 brings together technologies such as artificial intelligence (AI),...
The proteomics market is entering a strong growth phase as advances in protein analysis, precision medicine, biomarker discovery, and clinical diagnostics expand its role across healthcare and life sciences. The market was valued at USD 38.4 billion in 2025 and is estimated to reach USD 43.7 billion in 2026, before growing to USD 97.7 billion by 2033, representing a CAGR of 12.2% from 2026 to...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek